Need a Drug to Save Your Life? This Obamacare App May Prevent You From Getting It
by Wesley J. Smith | Washington, DC | LifeNews.com | 7/17/14 9:28 AM
Obamacare’s emphasis on cost-benefit has apparently granted permission for the medical technocrats to conjure all kinds of healthcare rationing schemes.
And the Medical Establishment is apparently playing along. From, “The Cancer Death-Panel App,” by Robert Goldberg in the NY Post:
The latest innovation in cancer care isn’t a medical breakthrough but an app to ration new drugs. It’ll measure care in terms of what it costs health plans, instead of what it means for patients’ lives.
That it’s being developed under the auspices of the American Society for Clinical Oncology, or ASCO, the world’s leading oncology association, is a grim warning about the state of organized medicine.
The app will use an algorithm like those many health plans apply to limit access to innovative treatments. Wellpoint Inc., for one, measures cost-effectiveness by comparing the benefits, side effects and costs of various treatments for specific types of cancer. The ASCO app uses the same benchmarks.
So, it is the end of treating patients as individuals, as we expand healthcare into areas that don’t treat illness but expensively enable desired lifestyles.
We are all just cattle now. Mooo.
Read the entire column. It is very sobering.
LifeNews.com Note: Wesley J. Smith, J.D., is a special consultant to the Center for Bioethics and Culture and a bioethics attorney who blogs at Human Exeptionalism.